Akers Biosciences, Inc. AKER Balance Sheet

Akers biosciences, inc. (AKER)

Balance Sheet / TTM

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13
Schedule of Finite-Lived Intangible Assets [Table]
ASSETS
Current Assets
Cash
812	517	363	248	275	181	1,301	275	647	438	135	197	2,085	72	195	379	180	402	393	261	336	455	642	402	305	103
Marketable Securities
6,629	9,164	2,845	4,020	4,477	5,272	4,866	7,977	8,679	5,011	10	1,011	157	50	599	1,548	2,442	4,025	5,229	6,416	8,058	9,264	10,206	11,444	12,498	0
Trade Receivables, net
321	42	230	266	324	176	283	412	416	964	1,125	927	517	601	738	542	781	609	1,109	1,901	1,134	1,154	1,076	1,045	138	118
Trade Receivables - Related Party, net
-	-	-	-	-	-	-	-	-	-	0	0	24	31	31	31	31	31	0	0	864	864	1,475	1,475	1,475	1,209
Notes Receivable - Related Party, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	299	273	291	266	-	-	-	0
Deposits and other receivables
-	-	-	-	-	9	30	30	29	16	21	13	13	23	29	64	49	95	101	33	26	41	-	-	-	748
Deposits and other receivables - Related Party
-	-	-	-	-	-	30	30	33	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Other Receivables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	60	17	34	-
Inventories, net
193	198	412	544	601	585	807	1,014	973	947	2,148	2,228	2,169	2,036	1,942	1,217	1,212	1,131	955	821	969	905	784	752	665	1,025
Prepaid expenses
339	387	463	169	283	444	513	693	234	396	99	147	98	168	94	142	138	185	-	-	-	-	-	-	-	-
Prepaid expenses - Related Party
-	-	-	-	-	-	77	136	148	-	380	317	263	202	214	-	-	0	-	-	-	-	-	-	-	-
Other Current Assets
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	169	175	128	107	66	101	45	163
Total Current Assets
8,296	10,310	4,315	5,249	5,962	6,670	7,910	10,571	11,163	7,775	3,920	4,843	5,329	3,186	3,846	3,925	4,836	6,481	8,257	9,883	11,808	13,059	14,312	15,239	15,163	3,369
Non-Current Assets
Prepaid expenses
252	252	260	-	-	298	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses
-	-	-	267	276	-	-	-	-	120	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Prepaid expenses - Related Party
-	-	-	-	-	-	273	208	209	-	53	108	192	270	276	-	-	0	-	-	-	-	-	-	-	-
Restricted Cash
115	115	115	115	480	500	500	500	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Notes Receivable - Related Party, net
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,000	1,071	1,140	1,209	-	-	-	0
Property, Plant and Equipment, net
26	33	58	68	78	83	258	245	259	235	242	260	258	259	245	304	321	251	214	214	230	201	224	224	245	267
Operating Lease Right-of-Use Asset
269	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Intangible Assets, net
158	170	213	223	233	243	1,002	1,045	1,087	1,130	1,173	1,216	1,258	1,301	1,344	1,387	1,430	1,472	1,515	2,046	2,111	2,176	2,240	2,305	2,369	2,434
Other Assets
2	2	7	7	12	12	76	76	76	76	76	71	66	66	66	66	66	66	66	68	68	4	4	4	4	4
Total Non-Current Assets
825	574	655	682	1,080	1,137	2,110	2,075	1,633	1,561	1,545	1,656	1,776	1,898	1,933	1,758	1,818	1,790	2,797	3,400	3,551	3,591	2,469	2,534	2,619	2,706
Total Assets
9,121	10,884	4,971	5,931	7,042	7,807	10,020	12,646	12,796	9,337	5,465	6,499	7,105	5,085	5,779	5,684	6,654	8,271	11,054	13,284	15,360	16,650	16,782	17,773	17,782	6,075
LIABILITIES
Current Liabilities
Trade and Other Payables
2,033	1,529	1,372	1,617	2,076	1,973	2,254	1,835	1,360	1,785	1,637	1,501	1,263	1,463	1,249	1,565	1,543	1,668	1,256	1,164	928	1,538	-	-	-	1,000
Operating Lease Liability
146	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Trade and Other Payables
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	666	638	609	-
Trade and Other Payables - Related Party
-	-	-	-	-	-	47	16	19	-	20	33	95	234	59	-	-	0	-	-	-	-	0	0	0	6
Short-Term Notes Payable - Related Party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	307
Deferred Revenue
-	-	-	-	-	-	-	-	-	-	12	-	-	-	-	-	-	-	0	0	222	305	333	333	333	333
Total Current Liabilities
2,179	1,529	1,372	-	-	1,973	2,301	1,851	1,379	-	1,670	1,535	1,359	1,697	1,309	1,565	1,543	1,668	1,256	1,164	1,151	1,843	999	971	943	1,647
Operating Lease Liability - non-current
124	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue - Related Party
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	55	138	222	305
Total Non-Current Liabilities
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	55	138	222	305
Total Liabilities
2,304	1,529	1,372	1,617	2,076	1,973	2,301	1,851	1,379	1,785	1,670	1,535	1,359	1,697	1,309	1,565	1,543	1,668	1,256	1,164	1,151	1,843	1,054	1,110	1,165	1,953
SHAREHOLDERS' EQUITY
Preferred stock, value
-	-	-	-	-	-	0	0	0	1,755	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Common stock, No par value, 100,000,000 shares authorized 2,915,240 and 1,738,837 issued and outstanding as of March 31, 2020 and December 31, 2019
129,743	128,920	121,822	121,699	121,574	121,554	119,582	119,580	118,139	110,647	104,628	104,624	104,594	100,891	100,886	100,848	100,793	100,785	100,388	100,388	100,388	99,691	99,691	99,494	98,944	85,843
Deferred Compensation
-	-	-	-	-	-	0	0	0	3	8	14	19	24	29	36	-	0	-	-	-	-	-	-	-	-
Accumulated Other Comprehensive Income (Loss)
-223	17	19	21	3	-25	-5	-12	-16	-	0	1	0	0	-2	0	2	-6	8	3	6	-20	-11	-3	-10	0
Accumulated Deficit
-123,121	-119,583	-118,243	-117,406	-116,611	-115,694	-111,857	-108,773	-106,705	-104,845	-100,824	-99,646	-98,828	-97,479	-96,383	-96,693	-95,684	-94,175	-90,599	-88,272	-86,185	-84,864	-83,951	-82,827	-82,316	-81,721
Total Shareholders' Equity
6,817	9,355	3,598	4,314	4,965	5,833	7,719	10,794	11,417	7,552	3,795	4,964	5,746	3,387	4,470	4,118	5,111	6,603	9,798	12,119	14,209	14,806	15,727	16,663	16,617	4,122
Total Liabilities and Shareholders' Equity
9,121	10,884	4,971	5,931	7,042	7,807	10,020	12,646	12,796	9,337	5,465	6,499	7,105	5,085	5,779	5,684	6,654	8,271	11,054	13,284	15,360	16,650	16,782	17,773	17,782	6,075
Series D Convertible Preferred Stock [Member]
Preferred stock, value
418	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders' Equity
418	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-